Company Name:DexCom Inc.
CEO: Kevin R. Sayer

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.


Key numbers

Market Capitalization:21332052840
Shares Outstanding: 91186000
Float: 89651704
Next Earning Date:2020-02-13
TTm EPS: -1.9374
TTm Dividend Rate:
200 days moving average:164.53
50 days moving average: 221.98
One day percent Change: -0.7



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,